Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Forte Biosciences, Inc. (FBRX) since 2017 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Forte Biosciences, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1419041.
Total stock buying since 2017: $2,280,499.
Total stock sales since 2017: $4,453,375.
Total stock option exercises since 2017: $4,793.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2025 | 0 | $0 | 0 | $0 | 3,250 | $0 |
| 2024 | 22,514 | $124,997 | 0 | $0 | 123,500 | $0 |
| 2023 | 118,865 | $75,032 | 0 | $0 | 144,375 | $0 |
| 2021 | 0 | $0 | 1,025,000 | $4,453,375 | 500 | $4,793 |
| 2020 | 153,150 | $373,971 | 0 | $0 | 0 | $0 |
| 2019 | 58,000 | $281,499 | 0 | $0 | 0 | $0 |
| 2017 | 142,500 | $1,425,000 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2025-07 | 0 | $0 | 0 | $0 | 1,625 | $0 |
| 2025-04 | 0 | $0 | 0 | $0 | 1,625 | $0 |
| 2024-11 | 22,514 | $124,997 | 0 | $0 | 0 | $0 |
| 2024-10 | 0 | $0 | 0 | $0 | 1,625 | $0 |
| 2024-07 | 0 | $0 | 0 | $0 | 40,625 | $0 |
| 2024-04 | 0 | $0 | 0 | $0 | 40,625 | $0 |
| 2024-01 | 0 | $0 | 0 | $0 | 40,625 | $0 |
| 2023-12 | 111,499 | $71,851 | 0 | $0 | 0 | $0 |
| 2023-11 | 7,366 | $3,181 | 0 | $0 | 0 | $0 |
| 2023-10 | 0 | $0 | 0 | $0 | 48,125 | $0 |
| 2023-07 | 0 | $0 | 0 | $0 | 48,125 | $0 |
| 2023-04 | 0 | $0 | 0 | $0 | 48,125 | $0 |
| 2021-09 | 0 | $0 | 1,025,000 | $4,453,375 | 0 | $0 |
| 2021-01 | 0 | $0 | 0 | $0 | 500 | $4,793 |
| 2020-06 | 13,700 | $197,798 | 0 | $0 | 0 | $0 |
| 2020-04 | 74,301 | $88,418 | 0 | $0 | 0 | $0 |
| 2020-03 | 65,149 | $87,755 | 0 | $0 | 0 | $0 |
| 2019-05 | 58,000 | $281,499 | 0 | $0 | 0 | $0 |
| 2017-04 | 142,500 | $1,425,000 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-07-01 | Wagner Paul A. (SEE REMARKS) | Option Ex | 1,250 | .00 | 0 |
| 2025-07-01 | Riley Antony A (CHIEF FINANCIAL OFFICER) | Option Ex | 375 | .00 | 0 |
| 2025-04-01 | Wagner Paul A. (SEE REMARKS) | Option Ex | 1,250 | .00 | 0 |
| 2025-04-01 | Riley Antony A (CHIEF FINANCIAL OFFICER) | Option Ex | 375 | .00 | 0 |
| 2024-11-21 | Riley Antony A (CHIEF FINANCIAL OFFICER) | Buy | 22,514 | 5.55 | 124,997 |
| 2024-10-01 | Wagner Paul A. (SEE REMARKS) | Option Ex | 1,250 | .00 | 0 |
| 2024-10-01 | Riley Antony A (CHIEF FINANCIAL OFFICER) | Option Ex | 375 | .00 | 0 |
| 2024-07-01 | Wagner Paul A. (SEE REMARKS) | Option Ex | 31,250 | .00 | 0 |
| 2024-07-01 | Riley Antony A (CHIEF FINANCIAL OFFICER) | Option Ex | 9,375 | .00 | 0 |
| 2024-04-01 | Wagner Paul A. (SEE REMARKS) | Option Ex | 31,250 | .00 | 0 |
| 2024-04-01 | Riley Antony A (CHIEF FINANCIAL OFFICER) | Option Ex | 9,375 | .00 | 0 |
| 2024-01-01 | Wagner Paul A. (See Remarks) | Option Ex | 31,250 | .00 | 0 |
| 2024-01-01 | Riley Antony A (Chief Financial Officer) | Option Ex | 9,375 | .00 | 0 |
| 2023-12-18 | Wagner Paul A. (See Remarks) | Buy | 10,000 | .75 | 7,530 |
| 2023-12-14 | Wagner Paul A. (See Remarks) | Buy | 10,000 | .72 | 7,200 |
| 2023-12-13 | Wagner Paul A. (See Remarks) | Buy | 10,520 | .70 | 7,353 |
| 2023-12-12 | Wagner Paul A. (See Remarks) | Buy | 4,776 | .65 | 3,090 |
| 2023-12-11 | Wagner Paul A. (See Remarks) | Buy | 25,000 | .65 | 16,200 |
| 2023-12-08 | Wagner Paul A. (See Remarks) | Buy | 15,000 | .62 | 9,300 |
| 2023-12-07 | Wagner Paul A. (See Remarks) | Buy | 36,203 | .58 | 21,178 |
| 2023-11-22 | Wagner Paul A. (See Remarks) | Buy | 400 | .43 | 172 |
| 2023-11-20 | Wagner Paul A. (See Remarks) | Buy | 6,966 | .43 | 3,009 |
| 2023-10-01 | Chen Hubert C (See remarks) | Option Ex | 7,500 | .00 | 0 |
| 2023-10-01 | Wagner Paul A. (See Remarks) | Option Ex | 31,250 | .00 | 0 |
| 2023-10-01 | Riley Antony A (Chief Financial Officer) | Option Ex | 9,375 | .00 | 0 |
| 2023-07-01 | Chen Hubert C (See remarks) | Option Ex | 7,500 | .00 | 0 |
| 2023-07-01 | Wagner Paul A. (See Remarks) | Option Ex | 31,250 | .00 | 0 |
| 2023-07-01 | Riley Antony A (Chief Financial Officer) | Option Ex | 9,375 | .00 | 0 |
| 2023-04-01 | Chen Hubert C (See remarks) | Option Ex | 7,500 | .00 | 0 |
| 2023-04-01 | Wagner Paul A. (See Remarks) | Option Ex | 31,250 | .00 | 0 |
| 2023-04-01 | Riley Antony A (Chief Financial Officer) | Option Ex | 9,375 | .00 | 0 |
| 2021-09-07 | Wagner Paul A. (See Remarks) | Sale | 1,000,000 | 4.35 | 4,347,000 |
| 2021-09-07 | Riley Antony A (Chief Financial Officer) | Sale | 25,000 | 4.25 | 106,375 |
| 2021-01-13 | Darcy Thomas E (Director) | Option Ex | 500 | 9.59 | 4,793 |
| 2020-06-29 | Riley Antony A (Chief Financial Officer) | Buy | 2,000 | 14.11 | 28,220 |
| 2020-06-26 | Riley Antony A (Chief Financial Officer) | Buy | 4,700 | 14.52 | 68,225 |
| 2020-06-25 | Wagner Paul A. (See Remarks) | Buy | 7,000 | 14.48 | 101,353 |
| 2020-04-14 | Oliveira Steven Michael | Buy | 74,301 | 1.19 | 88,418 |
| 2020-03-02 | Oliveira Steven Michael | Buy | 65,149 | 1.35 | 87,755 |
| 2019-05-30 | Hasnain Faheem (Director) | Buy | 43,000 | 5.01 | 215,559 |
| 2019-05-28 | Duvall Martin J (Chief Executive Officer) | Buy | 5,000 | 4.34 | 21,680 |
| 2019-05-28 | Foletta Mark G (EVP & Chief Financial Officer) | Buy | 5,000 | 4.29 | 21,475 |
| 2019-05-24 | Gruber Harry E (President, Science&Innovation) | Buy | 5,000 | 4.56 | 22,785 |
| 2017-04-19 | Das Asha (SVP & Chief Medical Officer) | Buy | 2,500 | 10.00 | 25,000 |
| 2017-04-19 | Hasnain Faheem (Director) | Buy | 100,000 | 10.00 | 1,000,000 |
| 2017-04-19 | Schimmel Paul (Director) | Buy | 10,000 | 10.00 | 100,000 |
| 2017-04-19 | Foletta Mark G (EVP & Chief Financial Officer) | Buy | 5,000 | 10.00 | 50,000 |
| 2017-04-19 | Gruber Harry E (President, Research & Devel) | Buy | 25,000 | 10.00 | 250,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of FBRX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Forte Biosciences, Inc. (symbol FBRX, CIK number 1419041) see the Securities and Exchange Commission (SEC) website.